查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992930

Erucamide市場：2026-2032年全球市場按產品類型、技術、應用和最終用途行業分類的預測

Erucamide Market by Product Type, Technology, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年， Erucamide市場價值將達到 2.8658 億美元，到 2026 年將成長至 2.9962 億美元，到 2032 年將達到 3.8539 億美元，複合年成長率為 4.32%。

主要市場統計數據
基準年 2025 2.8658億美元
預計年份：2026年 2.9962億美元
預測年份 2032 3.8539億美元
複合年成長率 (%) 4.32%

對Erucamide的化學性質、工業應用、加工注意事項以及知情決策者所需的實用框架進行了簡明扼要的基礎性說明。

Erucamide已成為聚合物、潤滑劑和表面改質劑領域中至關重要的潤滑劑和加工助劑，並廣泛應用於整體製造業。本執行摘要概述了Erucamide在現代生產環境中的作用，重點介紹了其理化性質、與聚烯的相容性以及在改善表面觸感、摩擦性能和加工穩定性方面的效用。讀者將清楚了解Erucamide在價值鏈中的定位、它如何與常用樹脂系統相互作用，以及為何材料工程師和採購負責人越來越關注其規格和採購。

原料來源的演變、永續發展優先事項、監管變化以及加工技術的創新如何重新定義Erucamide的用途和供應鏈策略。

隨著原料採購管道、永續發展優先事項以及下游製程配方偏好的同步演變，Erucamide）的市場格局正在迅速變化。在整個價值鏈中，籌資策略都在不斷調整，以應對日益嚴格的原料價格波動和生命週期影響監測，這迫使配方生產商重新評估添加劑的性能標準，並要求供應商提高可追溯性。加工技術和混煉技術的進步拓展了Erucamide的有效應用範圍，使其不再局限於傳統的潤滑劑應用，從而在低溫下實現了更佳的遷移控制，並增強了其與先進聚烯共混物的相容性。

2025 年美國關稅調整將如何影響整個添加劑供應鏈的採購行為、供應商多元化和庫存策略？

2025年美國關稅調整對籌資策略、供應商選擇和供應鏈緊急時應對計畫產生了實際的影響。進口關稅改變了出口商的收貨成本差異，並將採購討論的重點轉向國內生產的韌性和供應商網路的多元化。因此，買家重新評估了與供應商的長期合作關係，並加快了二級資訊認證流程，以確保供應的連續性。

可操作的細分資訊揭示了應用、最終用途行業、產品類型和生產技術如何決定Erucamide的適用性和供應商選擇。

細分市場分析揭示了影響依Erucamide選擇和配方策略的特定應用因素和技術要求。根據應用領域，電纜和電線、擠出成型、射出成型和包裝薄膜的市場動態各不相同。包裝薄膜尤其需要關注，因為它們又細分為雙軸延伸聚丙烯(BOPP)、高密度聚苯乙烯(HDPE) 和低密度聚乙烯 (LDPE)，每種材料對遷移和透明度都有不同的限制。在電纜和電線應用中，電氣相容性和熱穩定性是優先考慮的因素；而在擠出成型和射出成型中，加工窗口容差和母粒系統的均質性則至關重要。

區域比較分析重點闡述了美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響供應可靠性、合規預期和商業策略。

區域趨勢決定了供應鏈結構、監管摩擦以及製造商和買家必須應對的競爭強度。在美洲，由於接近性主要的聚合物加工商，且高度重視近岸採購，因此對穩定的供應模式和可預測的物流的需求日益成長。該地區的生產商通常優先考慮卡車直達工廠的配送模式以及支援準時生產和快速配方調整的供應商夥伴關係。

與推動Erucamide整個供應鏈可靠性、技術差異化和快速認證的公司建立競爭性和策略性夥伴關係。

Erucamide價值鏈中的主要企業擁有卓越的技術、柔軟性的供應鏈以及對品質保證的堅定承諾。投資於先進蒸餾和加氫等煉油技術的市場參與企業，能夠持續實現高價值應用所需的更嚴格的雜質控制和可重複的產品規格。同樣重要的是，那些已建立多模態物流和區域倉儲的企業，這使它們能夠更快地應對需求波動和關稅相關的干擾。

為製造商和買家提供切實可行的優先策略措施，以增強供應韌性、加快產品客製化進程，並在高度波動的貿易環境中保護利潤率。

產業領導者應優先採取一系列切實可行的措施來增強韌性並創造商業性優勢。首先，供應商分佈應多元化，以平衡成本、地理風險和品質穩定性。關鍵等級產品的雙重採購以及對區域供應商進行認證可以減少單點故障。其次，投資於能夠加速產品客製化並促進與加工商共同開發的技術夥伴關係。這將縮短新配方的上市時間，並實現針對性能目標的快速迭代改進。

採用嚴謹的混合方法研究途徑，結合專家訪談、技術文獻回顧與供應鏈映射，檢驗Erucamide的績效與商業性趨勢。

本分析的調查方法結合了定性專家訪談、技術文獻綜述和供應鏈圖譜分析，以全面觀點Erucamide的發展趨勢。研究重點包括與配料負責人、採購經理、製程工程師和物流專家進行討論，以了解實際的限制因素和應用標準。基於這些對話，研究人員對生產技術、操作特性和特定應用性能要求進行了系統評估。

對Erucamide在績效、合規性和供應鏈韌性方面的策略角色進行綜合分析，凸顯了跨職能決策的必要性。

Erucamide在聚合物添加劑產品組合中佔據著至關重要的地位，它完美地融合了材料性能、加工性能和法規遵從性。從整體情況來看，該材料的效用涵蓋多個工業領域，每個領域都面臨獨特的技術和商業性壓力，這些壓力會影響產品設計和採購選擇。相關人員使其配方策略與不斷變化的法規預期保持一致，並投資於多元化的採購和技術進步，就能更清楚地實現商業性穩定性和產品差異化。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章： Erucamide市場：依產品類型分類

  • 顆粒
  • 液體
  • 顆粒
  • 粉末

第9章： Erucamide市場：依技術分類

  • 蒸餾
  • 氫化
  • 溶劑萃取

第10章： Erucamide市場：依應用領域分類

  • 電線電纜
  • 擠壓
  • 射出成型
  • 包裝膜
    • 雙軸延伸聚丙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯

第11章： Erucamide市場：以最終用途產業分類

  • 車
  • 建造
  • 電子與電機工程
  • 鞋類和皮革
  • 包裝
    • 軟包裝
    • 工業包裝
    • 硬包裝

第12章： Erucamide市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章： Erucamide市場：依集團分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章Erucamide市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國Erucamide市場

第16章：中國Erucamide市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aceto Corporation
  • Arkema SA
  • Biosynth AG
  • Cayman Chemical Company
  • Clearsynth Labs Ltd.
  • Croda International Plc
  • GSA Chemical Corporation
  • Haihang Industry Co., Ltd.
  • Hangzhou DayangChem Co., Ltd.
  • High Grade Industries India Private Limited
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Jiangxi Hongyuan Chemical Co., Ltd.
  • Merck KGaA
  • Nippon Fine Chemical Co., Ltd.
  • Oleon NV
  • Parchem Fine & Specialty Chemicals, Inc.
  • PMC Biogenix, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Shandong Chuangxin Biotechnology Co., Ltd.
  • Sigma-Aldrich Chemicals Private Limited
  • Spectrum Chemical Mfg. Corp.
  • Tokyo Chemical Industry Co., Ltd.
  • Zhejiang Wumei Biotechnology Co., Ltd.
Product Code: MRR-1A1A064C0127

The Erucamide Market was valued at USD 286.58 million in 2025 and is projected to grow to USD 299.62 million in 2026, with a CAGR of 4.32%, reaching USD 385.39 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 286.58 million
Estimated Year [2026] USD 299.62 million
Forecast Year [2032] USD 385.39 million
CAGR (%) 4.32%

Concise foundational orientation to erucamide chemistry, industrial utility, processing considerations, and the practical framework decision-makers need for informed actions

Erucamide has emerged as a pivotal slip agent and processing aid in polymers, lubricants, and surface modifiers, with broad relevance across manufacturing verticals. This executive summary frames erucamide's role within contemporary production environments, emphasizing its physicochemical attributes, compatibility with polyolefins, and utility in enhancing surface feel, frictional properties, and processing stability. Readers will gain a clear sense of where erucamide integrates into value chains, how it interacts with typical resin systems, and why material engineers and procurement professionals increasingly focus on its specification and sourcing.

The following content synthesizes technical characteristics with practical considerations for industrial adoption. It bridges laboratory performance with industrial-scale requirements, highlighting manufacturing variables such as melt flow behavior, additive migration, and thermal stability under common processing regimes. The intent is to orient decision-makers to the product's practical benefits and constraints, while setting a shared vocabulary for subsequent sections that address regulatory adjustments, trade environments, segmentation complexity, regional dynamics, and corporate strategies.

How evolving feedstock sources, sustainability priorities, regulatory shifts, and processing innovations are redefining erucamide applications and supply chain strategies

The erucamide landscape is shifting rapidly as raw material pathways, sustainability priorities, and downstream formulation preferences evolve in parallel. Across the value chain, sourcing strategies are adapting to feedstock volatility and increased scrutiny over lifecycle impacts, pushing formulators to reassess additive performance criteria and suppliers to enhance traceability. Advances in processing technologies and compounding approaches have expanded the effective use cases for erucamide beyond traditional slip applications, enabling improved low-temperature migration control and compatibility with advanced polyolefin blends.

Concurrently, regulatory and commercial pressures are accelerating the pursuit of greener chemistries and alternative supply networks. Brand owners are integrating additive-level transparency into their sustainability narratives, which in turn prompts processors to secure verifiable supply chains and consider secondary parameters such as biodegradability profiles and renewable feedstock sourcing. These forces intersect with technological innovation: enhanced distillation and hydrogenation routes alongside solvent extraction refinements have raised the bar for consistency and impurity control, which supports higher-value applications and longer product lifecycles. Together, these shifts are redefining how erucamide is specified, procured, and positioned within product portfolios.

How the 2025 United States tariff adjustments reshaped procurement behavior, supplier diversification, and inventory strategies across additive supply chains

United States tariff adjustments in 2025 created tangible ripple effects across sourcing strategies, supplier selection, and supply chain contingency planning. Import duties altered relative landed cost differentials for exporters and redirected procurement conversations toward domestic production resilience and diversified supplier networks. As a direct consequence, buyers reassessed long-standing supplier relationships and accelerated qualification timelines for secondary sources to preserve continuity of supply.

These tariff-driven dynamics also stimulated deeper collaboration between buyers and manufacturers to redesign procurement contracts with clauses that address duty pass-through, inventory staging, and shared risk for supply interruptions. Logistics planners adjusted inbound routing and inventory positions to reduce exposure to ports and customs treatments that incurred higher duty liabilities. At the same time, manufacturers prioritized near-shoring and investment in local compounding capabilities to minimize import dependency for critical additive volumes. The net effect emphasized operational agility: organizations that integrated tariff scenario planning into sourcing playbooks and stress-tested supplier capacity performed better in maintaining production schedules, while those reliant on a narrow set of foreign suppliers faced more acute short-term disruptions.

Actionable segmentation intelligence revealing how application, end-use industry, product type, and production technology determine erucamide suitability and supplier selection

Segmentation insights illuminate application-specific drivers and technical requirements that influence erucamide selection and formulation tactics. Based on Application, market dynamics vary between Cable & Wire, Extrusion, Injection Molding, and Packaging Films, with the latter category demanding particular attention because Packaging Films subdivide into Biaxial Oriented Polypropylene, High Density Polyethylene, and Low Density Polyethylene, each imposing distinct migration and clarity constraints. Cable & Wire applications prioritize electrical compatibility and thermal stability, whereas extrusion and injection molding emphasize processing window resilience and homogenization in masterbatch systems.

When viewed through the lens of End Use Industry, sectoral priorities further refine product specifications. Automotive applications demand thermal endurance and low-bleed profiles to maintain aesthetic and functional surfaces, while Construction markets value durability and weathering resistance. Electronics & Electrical segments require additive purity to avoid interference with sensitive components, and Footwear & Leather leverage slip and feel improvements to enhance consumer perception. The Packaging vertical, which is analyzed as Flexible Packaging, Industrial Packaging, and Rigid Packaging, places a premium on clarity, anti-blocking performance, and regulatory compliance for food contact when relevant.

Product Type segmentation clarifies handling, formulation, and dosing considerations. Granule, Liquid, Pellet, and Powder forms present distinct advantages and constraints for dosing accuracy, dispersion efficiency, and worker safety. Liquid formats facilitate rapid blending but necessitate solvent management, while granules and pellets typically offer easier handling and consistent dosing in automated compounding lines. Powder forms require enhanced dust control and dispersion technologies to achieve uniform additive distribution.

Technology choices govern production cost profile and impurity control. Distillation routes excel at delivering narrow boiling point fractions and therefore support higher-purity grades, Hydrogenation pathways reduce unsaturation-related instability and can improve color and odor profiles, and Solvent Extraction techniques offer selective removal of undesired constituents. Each technological approach yields trade-offs between capital intensity, environmental footprint, and achievable product performance, shaping supplier capabilities and the technical fit for end-use requirements.

Comparative regional analysis highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence supply reliability, compliance expectations, and commercial strategies

Regional dynamics dictate supply chain architecture, regulatory friction, and the competitive intensity that manufacturers and buyers must navigate. In the Americas, proximity to major polymer converters and a pronounced focus on near-shore sourcing drive demand for consistent supply profiles and logistics predictability. Producers in this region often emphasize truck-to-plant distribution models and supplier partnerships that support just-in-time manufacturing and rapid formulation changes.

Europe, Middle East & Africa present a diverse regulatory and market landscape where sustainability mandates and stringent product stewardship expectations shape purchasing behavior. Chemical regulations and extended producer responsibility frameworks encourage producers to highlight traceability and impurity control. In these markets, local compliance, certifications, and demonstrated lifecycle assessments play a larger role in procurement qualification than in some other regions.

Asia-Pacific encompasses varied production bases and a dense concentration of polymer processing capacity, which sustains a broad set of erucamide application opportunities. Manufacturing hubs within this region frequently leverage integrated supply chains that offer scale advantages, while regional demand exhibits rapid responsiveness to changes in consumer packaging trends and industrial expansion. Across all regions, cross-border logistics complexity, lead-time sensitivity, and differing regulatory thresholds converge to influence supplier selection and risk management strategies.

Competitive company attributes and strategic partnerships that drive reliability, technical differentiation, and faster qualification across the erucamide supply chain

Leading companies in the erucamide value chain exhibit a combination of technical excellence, supply chain flexibility, and a clear posture on quality assurance. Market participants that invest in refining technology, such as advanced distillation and hydrogenation capabilities, consistently achieve tighter impurity controls and more reproducible product specifications that appeal to high-value applications. Equally important, firms that establish multi-modal logistics options and regional warehousing can respond more rapidly to shifts in demand or tariff-related disruptions.

Strategic partnerships between additive producers and resin converters or compounders strengthen route-to-market effectiveness and shorten qualification cycles for end-users. Companies that offer formulation support, application testing, and co-development services differentiate themselves by reducing the integration friction for processors. Transparency around batch traceability, certificates of analysis, and adherence to relevant regulatory frameworks further enhances supplier credibility, especially when brand owners require verifiable supply chain information for sustainability reporting and compliance audits.

Practical and prioritized strategic moves for manufacturers and buyers to build supply resilience, accelerate product customization, and protect margins in a dynamic trade environment

Industry leaders should prioritize a set of actionable moves that enhance resilience and create commercial advantage. First, diversify supplier footprints to balance cost, geographic exposure, and quality consistency; dual-sourcing critical grades and qualifying regional suppliers reduces single-point failures. Second, invest in technical partnerships that accelerate product customization and co-development with converters, thereby shortening time-to-market for new formulations and enabling rapid iteration on performance targets.

Third, embed tariff and trade scenario planning into procurement playbooks to ensure pricing and logistics strategies remain adaptable. This involves establishing inventory buffers at strategic nodes, negotiating flexible contract terms with suppliers, and exploring bonded or free-trade arrangements where appropriate. Fourth, elevate documentation and traceability practices to support regulatory compliance and sustainability narratives; clear certificates of analysis, material origin data, and process transparency strengthen customer trust and facilitate market access in stricter regulatory environments. Finally, pursue targeted capital investment in refining and purification technologies to improve grade consistency and enable movement into higher-margin applications that demand low impurity and stable migration behavior.

Rigorous mixed-method research approach integrating expert interviews, technical literature review, and supply chain mapping to validate erucamide performance and commercial dynamics

The research methodology underpinning this analysis combined qualitative expert interviews, technical literature review, and supply chain mapping to generate a comprehensive perspective on erucamide dynamics. Primary engagements included discussions with formulators, procurement leads, process engineers, and logistics specialists to capture real-world constraints and adoption criteria. These conversations informed a structured assessment of production technologies, handling characteristics, and application-specific performance requirements.

Secondary research consolidated publicly available technical papers, regulatory documents, and patent filings to validate observed trends and identify technological maturation in distillation, hydrogenation, and solvent extraction processes. Supply chain mapping integrated customs data patterns and logistics route analysis to surface sensitivity points related to tariff changes and regional lead times. Throughout, analytical rigor focused on triangulating evidence across sources to ensure the conclusions reflect operational realities and not isolated anecdotes.

Synthesis of erucamide's strategic role across performance, compliance, and supply resilience that underscores the need for integrated cross-functional decision-making

Erucamide occupies a critical niche in polymer additive portfolios where material performance, processing behavior, and regulatory compliance intersect. The cumulative picture shows a material whose utility extends across multiple industrial domains, each with distinct technical and commercial pressures that influence product design and sourcing choices. Stakeholders that align formulation strategy with evolving regulatory expectations and invest in diversified sourcing and technological refinement will find clearer pathways to commercial stability and product differentiation.

Looking ahead, the interplay between supply chain resilience, technological advancement, and sustainability commitments will determine which participants capture the most value. Organizations that treat additive strategy as integral to product performance and supply continuity-rather than as a low-touch procurement item-will achieve stronger outcomes in both operational reliability and end-customer satisfaction. This conclusion underscores the importance of cross-functional alignment among R&D, procurement, and commercial teams to translate insight into action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Erucamide Market, by Product Type

  • 8.1. Granule
  • 8.2. Liquid
  • 8.3. Pellet
  • 8.4. Powder

9. Erucamide Market, by Technology

  • 9.1. Distillation
  • 9.2. Hydrogenation
  • 9.3. Solvent Extraction

10. Erucamide Market, by Application

  • 10.1. Cable & Wire
  • 10.2. Extrusion
  • 10.3. Injection Molding
  • 10.4. Packaging Films
    • 10.4.1. Biaxial Oriented Polypropylene
    • 10.4.2. High Density Polyethylene
    • 10.4.3. Low Density Polyethylene

11. Erucamide Market, by End Use Industry

  • 11.1. Automotive
  • 11.2. Construction
  • 11.3. Electronics & Electrical
  • 11.4. Footwear & Leather
  • 11.5. Packaging
    • 11.5.1. Flexible Packaging
    • 11.5.2. Industrial Packaging
    • 11.5.3. Rigid Packaging

12. Erucamide Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Erucamide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Erucamide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Erucamide Market

16. China Erucamide Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aceto Corporation
  • 17.6. Arkema S.A.
  • 17.7. Biosynth AG
  • 17.8. Cayman Chemical Company
  • 17.9. Clearsynth Labs Ltd.
  • 17.10. Croda International Plc
  • 17.11. GSA Chemical Corporation
  • 17.12. Haihang Industry Co., Ltd.
  • 17.13. Hangzhou DayangChem Co., Ltd.
  • 17.14. High Grade Industries India Private Limited
  • 17.15. Hunan Er-Kang Pharmaceutical Co., Ltd.
  • 17.16. Jiangxi Hongyuan Chemical Co., Ltd.
  • 17.17. Merck KGaA
  • 17.18. Nippon Fine Chemical Co., Ltd.
  • 17.19. Oleon NV
  • 17.20. Parchem Fine & Specialty Chemicals, Inc.
  • 17.21. PMC Biogenix, Inc.
  • 17.22. Santa Cruz Biotechnology, Inc.
  • 17.23. Shandong Chuangxin Biotechnology Co., Ltd.
  • 17.24. Sigma-Aldrich Chemicals Private Limited
  • 17.25. Spectrum Chemical Mfg. Corp.
  • 17.26. Tokyo Chemical Industry Co., Ltd.
  • 17.27. Zhejiang Wumei Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ERUCAMIDE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ERUCAMIDE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)